THE FOUNDATIONS
Learn the Science
Behind It
Start with a question. Open only what you want to explore.
01What is a peptide?
A peptide is a chain of amino acids joined together. Some carry messages; others bind metals or participate in chemical reactions.
For example. Think of a short word made from a molecular alphabet. Not every word is an instruction, and not every peptide is a messenger.
The science
Peptide bonds join amino-acid residues. Sequence, shape, charge and chemical modifications determine biological behavior. Shortness alone does not predict potency, safety or a target.
02What is an amino acid?
An amino acid is a building block used to make peptides and proteins. Its side group gives it its own chemical personality.
For example. Letters can form CAT or ACT. The same building blocks in a different order can make something with a different meaning.
The science
The standard protein-building amino acids have an amino group, carboxyl group and variable side chain. Side-chain chemistry influences folding, solubility and binding; modified and nonstandard amino acids also exist.
03What is a protein?
A protein is an amino-acid chain, or a group of chains, that folds into a working structure. Proteins can be scaffolds, enzymes, carriers or receptors.
For example. If a short peptide is a word, a protein is closer to a carefully folded instruction manual or a machine assembled from it.
The science
Protein function depends on primary sequence, local secondary structure and three-dimensional folding. Some proteins contain several subunits or attached sugars, metals or lipids.
04Peptide vs protein
Both are made from amino acids. Peptides are generally shorter; proteins are generally larger and more structurally complex.
For example. A bracelet and a woven garment can share building materials while having different sizes and jobs.
The science
There is no universally rigid length cutoff. Context matters: insulin is a peptide hormone with two chains, while hCG is a much larger glycoprotein hormone.
05Peptide vs hormone
Peptide describes structure. Hormone describes a signaling role. Some hormones are peptides, but others are not.
For example. “Made of wood” describes a material; “used to deliver mail” describes a job. Those are different kinds of labels.
The science
Insulin and oxytocin are peptide hormones. Cortisol is a steroid hormone. A peptide can act locally or have a nonsignaling role without being a circulating hormone.
06Natural vs synthetic peptides
Natural peptides arise in living organisms. Synthetic peptides are made using manufacturing processes and may copy or modify a natural sequence.
For example. A copied key can match the original, or its shape can be intentionally changed. Neither origin alone tells you whether it is appropriate or safe.
The science
Analogues may alter amino acids, introduce lipid groups or use other modifications to change stability and receptor activity. Identity, purity, formulation and clinical evidence matter more than the word natural.
07What is a receptor?
A receptor is a molecule, usually a protein, that recognizes a signal and can help a cell respond.
For example. In a large company, cells are employees, organs are departments, receptors are receiving stations and signaling molecules are messages. A lock and key is another useful analogy, but real receptors can adopt several shapes and recognize several molecules.
The science
Binding affinity is not the same as activation. Receptor location, expression, internalization and signaling partners determine the response. Some targets are enzymes or membrane lipids instead of classical receptors.
08What is an agonist?
An agonist binds a receptor and activates a response. Different agonists can activate it to different degrees.
For example. It is like pressing a doorbell, though different buttons may produce different volumes or patterns.
The science
Full, partial and biased agonists differ in efficacy and pathway selection. The observed response also depends on receptor density, concentration and the experimental system.
09What is an antagonist?
An antagonist blocks or reduces receptor activation by an agonist without producing the same activating response.
For example. It is like covering the doorbell so someone else cannot press it.
The science
Competitive antagonists compete at the same binding site; other antagonists act differently. Inverse agonists reduce constitutive receptor activity and are a distinct concept.
10What is a signaling pathway?
A pathway is a series of connected events that helps a cell respond to information.
For example. A message reaches a department, a manager passes it along and employees change what they do.
The science
Receptors can couple to G proteins, second messengers and protein kinases. Signals can affect secretion, metabolism, movement or gene expression. Pathways interact rather than operating as isolated lines.
11What does downstream signaling mean?
Downstream means the changes that follow an earlier molecular event.
For example. After the doorbell rings, a person hears it, walks to the door and decides whether to open it. Ringing the bell does not guarantee the final action.
The science
For example, Gs activation can stimulate adenylyl cyclase, increase cAMP and activate PKA. Feedback loops, cell type and parallel pathways alter the final response.
12What is bioavailability?
Bioavailability describes how much of an administered substance reaches the circulation unchanged. Getting into blood is not the same as reaching the intended tissue.
For example. A parcel may enter the shipping network without arriving intact at the correct address.
The science
Absorption, degradation and first-pass metabolism influence systemic exposure. Tissue penetration and intracellular uptake are separate questions. Results cannot be transferred between formulations or routes without evidence.
13What is half-life?
Half-life is the time it takes for an amount or concentration to fall by half under specified conditions.
For example. Imagine a tank losing half its contents each interval. That does not tell you exactly when a downstream biological effect ends.
The science
Pharmacokinetic half-life depends on distribution and clearance. Active metabolites, receptor occupancy and delayed signaling can separate plasma half-life from duration of biological activity. It is not a dosing instruction.
14What does investigational mean?
Investigational means a substance or use is being studied. It does not mean it has been shown safe or effective for general use.
For example. A prototype being tested is not the same as a finished, approved product.
The science
Clinical development commonly progresses through early safety studies and larger controlled studies. A trial listing, patent or orphan designation is not marketing approval. Regulatory status is specific to product, use and jurisdiction.
15Human clinical vs animal vs laboratory research
These are different settings for answering different questions. They are not interchangeable levels of proof.
For example. A car part on a workbench, a prototype on a test track and cars used by real drivers reveal different things.
The science
Laboratory studies isolate variables; animal models explore organism-level effects; human trials evaluate defined populations and endpoints. Human tissue experiments remain laboratory research, and observational human associations do not establish causation.
16Why evidence strength matters
A compelling explanation can still fail in a human trial. Confidence depends on the quality and consistency of the evidence for the exact claim.
For example. One enthusiastic review cannot carry the same weight as a well-designed comparison involving many people.
The science
Randomization, blinding, prespecified endpoints, appropriate controls, replication and complete adverse-event reporting improve confidence. Statistical significance alone does not show clinical importance or exclude bias.
READING THE RESEARCH
How strong is the evidence?
A finding in a cell is different from a finding in a person. Explore what each evidence label means.
Established or regulatory evidence
An approved product or substantial replicated clinical evidence exists for a defined use. This does not establish every proposed use or validate another formulation.
Human clinical research
People were studied under a clinical protocol. Look at randomization, the comparison group, sample size, endpoints and adverse events before judging the result.
Early human research
Small, preliminary or exploratory studies in people. A biomarker change or an uncontrolled observation is not a confirmed benefit.
Preclinical or animal research
Whole animals were studied. Differences in species, exposure and disease models limit translation to people.
Cell/laboratory research
Isolated cells, tissues or chemical systems were studied. Even human cells in a dish are not a human clinical trial.
Mechanistic research
A molecular interaction or proposed biological explanation is being investigated. Plausibility cannot establish an outcome.
Unknown or insufficient evidence
The evidence does not support a confident conclusion. Unknown safety does not mean safe.
A profile’s label summarizes the main evidence discussed, not every possible claim. Regulatory references concern the United States unless otherwise stated.
Continue your reading.
NHGRI · Amino acids
NHGRI · Proteins
ClinicalTrials.gov · How studies work